CTRI Number |
CTRI/2021/04/032663 [Registered on: 08/04/2021] Trial Registered Prospectively |
Last Modified On: |
30/03/2021 |
Post Graduate Thesis |
No |
Type of Trial |
Observational |
Type of Study
|
Follow Up Study |
Study Design |
Other |
Public Title of Study
|
Endometrial cancer - factors affecting disease recurrence |
Scientific Title of Study
|
Analysis of Clinicopathologic factors affecting the recurrence on carcinoma endometrium |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Anupama |
Designation |
Professor |
Affiliation |
Amrita Institute of Medical Sciences |
Address |
Dept. of Gynecologic Oncology
Amrita Institute of Medical Sciences
Kochi, Kerala, India
Ernakulam KERALA 682040 India |
Phone |
8891728600 |
Fax |
|
Email |
anupamarajanbabu@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Anupama |
Designation |
Professor |
Affiliation |
Amrita Institute of Medical Sciences |
Address |
Dept. of Gynecologic Oncology
Amrita Institute of Medical Sciences
Kochi, Kerala, India
Ernakulam KERALA 682040 India |
Phone |
8891728600 |
Fax |
|
Email |
anupamarajanbabu@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Anupama |
Designation |
Professor |
Affiliation |
Amrita Institute of Medical Sciences |
Address |
Dept. of Gynecologic Oncology
Amrita Institute of Medical Sciences
Kochi, Kerala, India
Ernakulam KERALA 682040 India |
Phone |
8891728600 |
Fax |
|
Email |
anupamarajanbabu@gmail.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
Amrita Institute |
Address |
Amrita Institute of Medical Sciences , Ernakulam, Kerala |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Anupama R |
Amrita Institute of Medical Sciences |
Ponekkara P O
Ernakulam
Kerala Ernakulam KERALA |
8891728600
anupamarajanbabu@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Amrita Institute |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: C541||Malignant neoplasm of endometrium, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Nil |
NIL |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
90.00 Year(s) |
Gender |
Female |
Details |
Patients with carcinoma endometrium |
|
ExclusionCriteria |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
Overall survival at 5 years |
Time of last follow up |
|
Secondary Outcome
|
Outcome |
TimePoints |
Recurrence free survival |
Date of recurrence |
|
Target Sample Size
|
Total Sample Size="300" Sample Size from India="300"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
28/04/2021 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="2" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
to be published after completion of the study |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
This is an analysis of factors affecting recurrence in patients with endometrial cancer. Once the study is completed we will be providing a summary of the findings and publication details |